Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Prentice, Jennifer R ^a   Clark, Matthew J ^a   Hoggard, Nigel ^a   Morton, Allison C ^b   Tooth, Claire ^b   Paley, Martyn N ^a   Stockley, Ian ^b   Hadjivassiliou, Marios ^b   Wilkinson, J Mark ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HIP OSTEOARTHRITIS; HUMAN; IMPLANTATION; MALE; METAL ON METAL HIP PROSTHESIS; METAL ON METAL HIP RESURFACING; TOTAL HIP PROSTHESIS; URINARY EXCRETION;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; MALE; METAL-ON-METAL JOINT PROSTHESES; MIDDLE AGED; OSTEOARTHRITIS, HIP; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878825654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066186     Document Type: Article

References (36)

1. Cohen D, (2012) How safe are metal-on-metal hip implants? BMJ 344: e1410.
2. Wilkinson JM, (2012) Metal-on-metal hip prostheses: where are we now? BMJ 345: e7792.
3. Heisel C, Streich N, Krachler M, Jakubowitz E, Kretzer JP, (2008) Characterization of the running-in period in total hip resurfacing arthroplasty: an in vivo and in vitro metal ion analysis. J Bone Joint Surg Am 90Suppl 3: 125-133.
4. Daniel J, Ziaee H, Pradhan C, Pynsent PB, McMinn DJ, (2007) Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty: four-year results of a prospective longitudinal study. J Bone Joint Surg Br 89: 169-173.
5. Steens W, von FG, Katzer A, (2006) Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-a case report. Acta Orthop 77: 830-832.
6. Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, et al. (2009) Loss of sight and sound. Could it be the hip? Lancet 373: 1052.
7. Oldenburg M, Wegner R, Baur X (2009) Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 24: 825 e815-820.
8. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, et al. (2010) Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 42: 140-143.
9. Tower SS, (2012) Arthroprosthetic cobaltism associated with metal on metal hip implants. BMJ 344: e430.
10. Rising JP, Reynolds IS, Sedrakyan A, (2012) Delays and difficulties in assessing metal-on-metal hip implants. N Engl J Med 367: e1.
11. Hartmann A, Lutzner J, Kirschner S, Witzleb WC, Gunther KP (2012) Do Survival Rate and Serum Ion Concentrations 10 Years After Metal-on-Metal Hip Resurfacing Provide Evidence for Continued Use? Clin Orthop Relat Res.
12. Holland JP, Langton DJ, Hashmi M, (2012) Ten-year clinical, radiological and metal ion analysis of the Birmingham Hip Resurfacing: from a single, non-designer surgeon. J Bone Joint Surg Br 94: 471-476.
13. Andrews RE, Shah KM, Wilkinson JM, Gartland A (2011) Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: Implications for skeletal health. Bone.
14. Linna A, Oksa P, Groundstroem K, Halkosaari M, Palmroos P, et al. (2004) Exposure to cobalt in the production of cobalt and cobalt compounds and its effect on the heart. Occup Environ Med 61: 877-885.
15. Mosteller RD, (1987) Simplified calculation of body-surface area. N Engl J Med 317: 1098.
16. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, et al. (2011) Biomarkers in chronic kidney disease: a review. Kidney Int 80: 806-821.
17. Legro RS, Finegood D, Dunaif A, (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83: 2694-2698.
18. Daniel J, Ziaee H, Pradhan C, McMinn DJ, (2009) Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings. J Bone Joint Surg Br 91: 176-179.
19. Back DL, Young DA, Shimmin AJ, (2005) How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clinical Orthopaedics and Related Research 438: 177-181.
20. Marker M, Grubl A, Riedl O, Heinze G, Pohanka E, et al. (2008) Metal-on-metal hip implants: do they impair renal function in the long-term? A 10-year follow-up study. Arch Orthop Trauma Surg 128: 915-919.
21. Hart AJ, Sabah SA, Bandi AS, Maggiore P, Tarassoli P, et al. (2011) Sensitivity and specificity of blood cobalt and chromium metal ions for predicting failure of metal-on-metal hip replacement. J Bone Joint Surg Br 93: 1308-1313.
22. Kwon YM, Ostlere SJ, McLardy-Smith P, Athanasou NA, Gill HS, et al. (2011) "Asymptomatic" pseudotumors after metal-on-metal hip resurfacing arthroplasty: prevalence and metal ion study. J Arthroplasty 26: 511-518.
23. Davda K, Lali FV, Sampson B, Skinner JA, Hart AJ, (2011) An analysis of metal ion levels in the joint fluid of symptomatic patients with metal-on-metal hip replacements. J Bone Joint Surg Br 93: 738-745.
24. Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, et al. (2010) Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: A consequence of excess wear. J Bone Joint Surg Br 92: 38-46.
25. De Smet K, De Haan R, Calistri A, Campbell PA, Ebramzadeh E, et al. (2008) Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am 90Suppl 4: 202-208.
26. Russell RG, Rogers MJ, (1999) Bisphosphonates: From the laboratory to the clinic and back again. Bone 25: 97-106.
27. Hua Y, Clark S, Ren J, Sreejayan N, (2012) Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem 23: 313-319.
28. McCarty MF, (1995) Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. Med Hypotheses 45: 241-246.
29. Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H, (2000) Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 17: 124-129.
30. Blake GM, Fogelman I, (2007) The correction of BMD measurements for bone strontium content. J Clin Densitom 10: 259-265.
31. Morin YL, Foley AR, Martineau G, Roussel J, (1967) Quebec beer-drinkers' cardiomyopathy: forty-eight cases. Can Med Assoc J 97: 881-883.
32. Wedeen RP, Qian LF, (1991) Chromium-induced kidney disease. Environ Health Perspect 92: 71-74.
33. Cartwright GE, (1955) The relationship of copper, cobalt, and other trace elements to hemopoiesis. Am J Clin Nutr 3: 11-19.
34. Quinteros FA, Poliandri AH, Machiavelli LI, Cabilla JP, Duvilanski BH, (2007) In vivo and in vitro effects of chromium VI on anterior pituitary hormone release and cell viability. Toxicol Appl Pharmacol 218: 79-87.
35. Costa ML, Achten J, Parsons NR, Edlin RP, Foguet P, et al. (2012) Total hip arthroplasty versus resurfacing arthroplasty in the treatment of patients with arthritis of the hip joint: single centre, parallel group, assessor blinded, randomised controlled trial. BMJ 344: e2147.
36. Penny JO, Ovesen O, Varmarken JE, Overgaard S (2013) Similar range of motion and function after resurfacing large-head or standard total hip arthroplasty. Acta Orthop.